首页 > 最新文献

Chinese Herbal Medicines最新文献

英文 中文
Genome-wide identification and characterization of methyltransferase involved in benzylisoquinoline alkaloids biosynthesis from Menispermum dauricum 桃毛月桂草合成苯基异喹啉生物碱甲基转移酶的全基因组鉴定与特性研究
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.11.007
Yuwei Ma , Yaning Fu , Ge Bai , Shancen Zhao , Ya Tian , Ziyuan Zhao , Yan Wang , Zhichao Xu , Yong Chen , Zhoujie An , Ranran Gao

Objective

Benzylisoquinoline alkaloids (BIAs) are valuable plant metabolites whose structural diversity largely depends on O-/N-methyltransferases (OMTs/NMTs). Although the CYP450-mediated backbone formation of BIAs was previously elucidated in Menispermum dauricum DC., the specific OMTs/NMTs responsible for their functional methylation remain unknown. This study aims to systematically identify and characterize these methyltransferases to define their roles in BIA biosynthesis.

Methods

Combining genomic and biochemical approaches, a genome-wide identification of methyltransferase (MT) genes was conducted using the published M. dauricum genome. The candidate MTs were functionally evaluated through in vitro enzymatic assays employing diverse BIA substrates to determine their methylation specificities. The substrate-binding modes of MdOMT1 and MdOMT11 were predicted and compared by protein modeling and molecular docking.

Results

Functional characterization of the 75 methyltransferases identified in the M. dauricum genome revealed four key enzymes (three OMTs and one NMT) that contribute to the diversification of BIA scaffolds through their distinct substrate specificities and positional preferences. Specifically, MdOMT1 preferentially catalyzed O-methylation at C7 position of 1-benzylisoquinolines (1-BIAs) and C2 position of tetrahydroprotoberberines. In contrast, MdOMT11 exhibited superior affinity and a strong preference for O-methylation at the C9 position of (S)-scoulerine. Meanwhile, MdNMT3 demonstrated effective N-methylation activity toward both 1-BIAs and tetrahydroprotoberberines.

Conclusion

This research elucidates the functional landscape of OMTs/NMTs in M. dauricum, revealing their crucial roles in BIA structural diversification. The newly identified enzymes provide valuable biocatalytic tools for synthetic biology approaches aimed at the sustainable and optimized production of high-value BIAs.
目的苯基异喹啉生物碱(BIAs)是一种有价值的植物代谢物,其结构多样性主要取决于O-/ n -甲基转移酶(OMTs/NMTs)。尽管cyp450介导的偏倚主干形成先前已在半月草DC中被阐明。,负责其功能性甲基化的特定omt / nmt仍然未知。本研究旨在系统地鉴定和表征这些甲基转移酶,以确定它们在BIA生物合成中的作用。方法采用基因组学和生物化学相结合的方法,利用已发表的稻壳菌基因组对甲基转移酶(MT)基因进行全基因组鉴定。候选MTs通过使用不同BIA底物的体外酶分析来评估其功能,以确定其甲基化特异性。通过蛋白建模和分子对接对MdOMT1和MdOMT11的底物结合模式进行了预测和比较。结果通过对75种甲基转移酶的功能分析,揭示了4种关键酶(3种omt和1种NMT)通过其不同的底物特异性和位置偏好促进BIA支架的多样化。具体来说,MdOMT1优先催化1-苄基异喹啉(1-BIAs)的C7位点和四氢原小檗碱的C2位点的o -甲基化。相比之下,MdOMT11在(S)-scoulerine的C9位置表现出更强的亲和力和对o -甲基化的强烈偏好。同时,MdNMT3对1-BIAs和四氢原小檗碱均表现出有效的n -甲基化活性。结论本研究阐明了M. dauricum中OMTs/NMTs的功能格局,揭示了它们在BIA结构多样化中的重要作用。新发现的酶为合成生物学方法提供了有价值的生物催化工具,旨在可持续和优化生产高价值的BIAs。
{"title":"Genome-wide identification and characterization of methyltransferase involved in benzylisoquinoline alkaloids biosynthesis from Menispermum dauricum","authors":"Yuwei Ma ,&nbsp;Yaning Fu ,&nbsp;Ge Bai ,&nbsp;Shancen Zhao ,&nbsp;Ya Tian ,&nbsp;Ziyuan Zhao ,&nbsp;Yan Wang ,&nbsp;Zhichao Xu ,&nbsp;Yong Chen ,&nbsp;Zhoujie An ,&nbsp;Ranran Gao","doi":"10.1016/j.chmed.2025.11.007","DOIUrl":"10.1016/j.chmed.2025.11.007","url":null,"abstract":"<div><h3>Objective</h3><div>Benzylisoquinoline alkaloids (BIAs) are valuable plant metabolites whose structural diversity largely depends on <em>O</em>-/<em>N</em>-methyltransferases (OMTs/NMTs). Although the CYP450-mediated backbone formation of BIAs was previously elucidated in <em>Menispermum dauricum</em> DC., the specific OMTs/NMTs responsible for their functional methylation remain unknown. This study aims to systematically identify and characterize these methyltransferases to define their roles in BIA biosynthesis.</div></div><div><h3>Methods</h3><div>Combining genomic and biochemical approaches, a genome-wide identification of methyltransferase (MT) genes was conducted using the published<!--> <em>M. dauricum</em> <!-->genome. The candidate MTs were functionally evaluated through <em>in vitro</em> enzymatic assays employing diverse BIA substrates to determine their methylation specificities. The substrate-binding modes of MdOMT1 and MdOMT11 were predicted and compared by protein modeling and molecular docking.</div></div><div><h3>Results</h3><div>Functional characterization of the 75 methyltransferases identified in the <em>M. dauricum</em> genome revealed four key enzymes (three OMTs and one NMT) that contribute to the diversification of BIA scaffolds through their distinct substrate specificities and positional preferences. Specifically, MdOMT1 preferentially catalyzed <em>O</em>-methylation at C7 position of 1-benzylisoquinolines (1-BIAs) and C2 position of tetrahydroprotoberberines. In contrast, MdOMT11 exhibited superior affinity and a strong preference for <em>O</em>-methylation at the C9 position of (<em>S</em>)-scoulerine. Meanwhile, MdNMT3 demonstrated effective <em>N</em>-methylation activity toward both 1-BIAs and tetrahydroprotoberberines.</div></div><div><h3>Conclusion</h3><div>This research elucidates the functional landscape of OMTs/NMTs in <em>M. dauricum</em>, revealing their crucial roles in BIA structural diversification. The newly identified enzymes provide valuable biocatalytic tools for synthetic biology approaches aimed at the sustainable and optimized production of high-value BIAs.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 97-109"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive genomic identification and functional analysis of bHLH transcription factors in Ganoderma lucidum 灵芝bHLH转录因子的基因组鉴定及功能分析
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.05.005
Jun Li , Xuewen Zhu , Yupeng Du , Wenxiao Chen , Jing Xu , Ying Wang , Shasha Zhou , Zhichao Xu , Shuangcheng Ma , Zhenhao Li , Wei Sun , Yaolei Mi

Objective

The basic helix-loop-helix (bHLH) transcription factors (TFs) are pivotal in regulating fungal growth, development, and secondary metabolism. However, the knowledge about the Ganoderma lucidum bHLHs (GlbHLHs) in ganoderic acid (GA) biosynthesis of G. lucidum was limited. This study aimed to explore the functions of bHLH genes in ganoderic acid biosynthesis during G. lucidum growth development.

Methods

First, the genome-wide identification of GlbHLHs was performed through Hidden Markov model searches and Two-way blast. Furthermore, through physicochemical properties, gene structure, and phylogenetic analysis, as well as combining the transcriptome and metabolome data from different developmental stages of G. lucidum, candidate GlbHLHs were screened. Subsequently, their regulatory roles in ganoderic acid biosynthesis were explored using yeast one-hybrid and dual-luciferase reporter assays.

Results

A total of 11 GlbHLH members were characterized in G. lucidum. The upstream promoter regions of these genes enriched hormones and abiotic stress responsive elements. Although individual ganoderic acid monomers demonstrated marked differences in accumulation patterns across specific growth phases and tissue types, overall, the total GA content was consistently higher in caps than in stipes throughout development. In addition, all GlbHLHs exhibited high expression in whole G. lucidum from the primordium to maturation stages. Among them, GlbHLH5 and GlbHLH7 showed the highest expression in any stage and highly correlated with key genes associated with GA pathway. Functional validation through dual-luciferase assays and yeast one-hybrid experiments had demonstrated that GlbHLH5 activated the P2 region of the lanosterol synthase promoter, while GlbHLH7 activated the promoters of squalene epoxidase and squalene synthase.

Conclusion

Compared to plants, G. lucidum harbored a small number of bHLH members but all high expression in any stages. Additionally, GlbHLH5 and GlbHLH7 with the highest expression among GlbHLHs showed activation in regulating the biosynthesis of GA. These results provide a theoretical reference for further research on ganoderic acid regulation in G. lucidum, and thereby providing a molecular foundation for enhancing ganoderic acid yield to optimize the medicinal value of G. lucidum.
目的碱性螺旋-环-螺旋(bHLH)转录因子(TFs)在真菌生长发育和次生代谢调控中起关键作用。然而,对灵芝酸(GA)生物合成中灵芝bHLHs (GlbHLHs)的认识有限。本研究旨在探讨灵芝生长发育过程中bHLH基因在灵芝酸生物合成中的作用。方法首先,通过隐马尔可夫模型搜索和双向blast对GlbHLHs进行全基因组鉴定。进一步,通过理化性质、基因结构、系统发育分析,结合裸子不同发育阶段的转录组和代谢组数据,筛选候选GlbHLHs。随后,利用酵母单杂交和双荧光素酶报告基因分析探讨了它们在灵芝酸生物合成中的调节作用。结果在灵芝中共鉴定出11个GlbHLH成员。这些基因的上游启动子区富含激素和非生物应激响应元件。尽管个别灵芝酸单体在特定生长阶段和组织类型中的积累模式存在显著差异,但总体而言,在整个发育过程中,帽型的总GA含量始终高于茎型。此外,所有GlbHLHs在整个裸子中从原基到成熟阶段都有高表达。其中GlbHLH5和GlbHLH7在各阶段表达量最高,且与GA通路相关的关键基因高度相关。双荧光素酶检测和酵母单杂交实验功能验证表明,GlbHLH5激活了羊毛甾醇合成酶启动子P2区域,GlbHLH7激活了角鲨烯环氧化酶和角鲨烯合成酶启动子。结论与植物相比,水灵草中bHLH成员数量较少,但在各阶段均有高表达。GlbHLHs中表达量最高的GlbHLH5和GlbHLH7对GA的生物合成具有调节作用。这些结果为进一步研究灵芝酸在灵芝中的调控提供了理论参考,从而为提高灵芝酸产率、优化灵芝药用价值提供了分子基础。
{"title":"Comprehensive genomic identification and functional analysis of bHLH transcription factors in Ganoderma lucidum","authors":"Jun Li ,&nbsp;Xuewen Zhu ,&nbsp;Yupeng Du ,&nbsp;Wenxiao Chen ,&nbsp;Jing Xu ,&nbsp;Ying Wang ,&nbsp;Shasha Zhou ,&nbsp;Zhichao Xu ,&nbsp;Shuangcheng Ma ,&nbsp;Zhenhao Li ,&nbsp;Wei Sun ,&nbsp;Yaolei Mi","doi":"10.1016/j.chmed.2025.05.005","DOIUrl":"10.1016/j.chmed.2025.05.005","url":null,"abstract":"<div><h3>Objective</h3><div>The basic helix-loop-helix (<em>bHLH</em>) transcription factors (TFs) are pivotal in regulating fungal growth, development, and secondary metabolism. However, the knowledge about the <em>Ganoderma lucidum bHLHs</em> (<em>GlbHLHs</em>) in ganoderic acid (GA) biosynthesis of <em>G</em>. <em>lucidum</em> was limited. This study aimed to explore the functions of <em>bHLH</em> genes in ganoderic acid biosynthesis during <em>G. lucidum</em> growth development.</div></div><div><h3>Methods</h3><div>First, the genome-wide identification of <em>GlbHLHs</em> was performed through Hidden Markov model searches and Two-way blast. Furthermore, through physicochemical properties, gene structure, and phylogenetic analysis, as well as combining the transcriptome and metabolome data from different developmental stages of <em>G. lucidum</em>, candidate <em>GlbHLHs</em> were screened. Subsequently, their regulatory roles in ganoderic acid biosynthesis were explored using yeast one-hybrid and dual-luciferase reporter assays.</div></div><div><h3>Results</h3><div>A total of 11 <em>GlbHLH</em> members were characterized in <em>G. lucidum</em>. The upstream promoter regions of these genes enriched hormones and abiotic stress responsive elements. Although individual ganoderic acid monomers demonstrated marked differences in accumulation patterns across specific growth phases and tissue types, overall, the total GA content was consistently higher in caps than in stipes throughout development. In addition, all <em>GlbHLH</em>s exhibited high expression in whole <em>G. lucidum</em> from the primordium to maturation stages. Among them, <em>GlbHLH5</em> and <em>GlbHLH7</em> showed the highest expression in any stage and highly correlated with key genes associated with GA pathway. Functional validation through dual-luciferase assays and yeast one-hybrid experiments had demonstrated that <em>GlbHLH5</em> activated the P2 region of the lanosterol synthase promoter, while <em>GlbHLH7</em> activated the promoters of squalene epoxidase and squalene synthase.</div></div><div><h3>Conclusion</h3><div>Compared to plants, <em>G. lucidum</em> harbored a small number of <em>bHLH</em> members but all high expression in any stages. Additionally, <em>GlbHLH5</em> and <em>GlbHLH7</em> with the highest expression among <em>GlbHLHs</em> showed activation in regulating the biosynthesis of GA. These results provide a theoretical reference for further research on ganoderic acid regulation in <em>G. lucidum</em>, and thereby providing a molecular foundation for enhancing ganoderic acid yield to optimize the medicinal value of <em>G. lucidum.</em></div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 200-211"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and synthesis of butyrolactone V derivatives and its anti-inflammatory activity analysis 丁内酯V衍生物的设计合成及其抗炎活性分析
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.03.004
Wen Liu , Biqiong Zhang , Zhengxi Hu , Si Yao , Yunpeng Zhao , Fengqing Wang , Yuanyuan Wang , Xinxin Yang , Jie Yin , Weiguang Sun , Qingyi Tong , Lianghu Gu , Yonghui Zhang

Objective

To design and synthesize an amount of butyrolactone V derivatives, evaluate the anti-inflammatory effects of all the derivatives, look for potential drugs that inhibit inflammatory bowel disease (IBD), and determine the structure-activity relationship (SAR).

Methods

The butyrolactone V derivatives were synthesized with high yield by oxidation reaction, substitution reaction, and esterification reaction in sequence, and the production of nitric oxide was assessed in RAW264.7 cells treated with the lipopolysaccharide and the compounds. Then, the target compounds were studied for their activity in dextran sodium sulfate (DSS)-induced ulcerative colitis.

Results

A total of three series of compounds encompassing 60 derivatives of the natural product butyrolactone V were designed and synthesized. The results showed that compounds 5p and 7e could alleviate the symptoms of DSS-induced colitis in mice, including alleviating diarrhea, inhibiting the reduction of colon length, and reducing tissue damage. The preliminary mechanism exploration indicated that compounds 5p and 7e could improve the symptoms of IBD in mice mainly by reducing the expression of chemokines and exerting anti-inflammatory effects.

Conclusion

This study reports the synthesis and the derivatization of butyrolactone V and analysis on anti-inflammatory activity. The most effective compounds 5p and 7e have the potential to be further developed as drugs to treat IBD.
目的设计合成一定量的丁内酯V衍生物,评价各衍生物的抗炎作用,寻找抑制炎症性肠病(IBD)的潜在药物,确定其构效关系(SAR)。方法通过氧化反应、取代反应和酯化反应,以高收率合成丁内酯V衍生物,并在经脂多糖和化合物处理的RAW264.7细胞中测定一氧化氮的生成。然后,研究了目标化合物在葡聚糖硫酸钠(DSS)诱导的溃疡性结肠炎中的活性。结果设计合成了天然产物丁内酯V共3个系列的60个衍生物。结果表明,化合物5p和7e可减轻dss诱导小鼠结肠炎的症状,包括减轻腹泻、抑制结肠长度缩短、减轻组织损伤。初步机制探索表明,化合物5p和7e主要通过降低趋化因子表达和抗炎作用改善小鼠IBD症状。结论本研究报道了丁内酯V的合成、衍生及抗炎活性分析。最有效的化合物5p和7e有可能被进一步开发成治疗IBD的药物。
{"title":"Design and synthesis of butyrolactone V derivatives and its anti-inflammatory activity analysis","authors":"Wen Liu ,&nbsp;Biqiong Zhang ,&nbsp;Zhengxi Hu ,&nbsp;Si Yao ,&nbsp;Yunpeng Zhao ,&nbsp;Fengqing Wang ,&nbsp;Yuanyuan Wang ,&nbsp;Xinxin Yang ,&nbsp;Jie Yin ,&nbsp;Weiguang Sun ,&nbsp;Qingyi Tong ,&nbsp;Lianghu Gu ,&nbsp;Yonghui Zhang","doi":"10.1016/j.chmed.2025.03.004","DOIUrl":"10.1016/j.chmed.2025.03.004","url":null,"abstract":"<div><h3>Objective</h3><div>To design and synthesize an amount of butyrolactone V derivatives, evaluate the anti-inflammatory effects of all the derivatives, look for potential drugs that inhibit inflammatory bowel disease (IBD), and determine the structure-activity relationship (SAR).</div></div><div><h3>Methods</h3><div>The butyrolactone V derivatives were synthesized with high yield by oxidation reaction, substitution reaction, and esterification reaction in sequence, and the production of nitric oxide was assessed in RAW264.7 cells treated with the lipopolysaccharide and the compounds. Then, the target compounds were studied for their activity in dextran sodium sulfate (DSS)-induced ulcerative colitis.</div></div><div><h3>Results</h3><div>A total of three series of compounds encompassing 60 derivatives of the natural product butyrolactone V were designed and synthesized. The results showed that compounds <strong>5p</strong> and <strong>7e</strong> could alleviate the symptoms of DSS-induced colitis in mice, including alleviating diarrhea, inhibiting the reduction of colon length, and reducing tissue damage. The preliminary mechanism exploration indicated that compounds <strong>5p</strong> and <strong>7e</strong> could improve the symptoms of IBD in mice mainly by reducing the expression of chemokines and exerting anti-inflammatory effects.</div></div><div><h3>Conclusion</h3><div>This study reports the synthesis and the derivatization of butyrolactone V and analysis on anti-inflammatory activity. The most effective compounds <strong>5p</strong> and <strong>7e</strong> have the potential to be further developed as drugs to treat IBD.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 142-152"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural novel vitamin C derivative, 2-O-β-D-glucopyranosyl-L-ascorbic acid: Resources, biosynthesis, and applications 天然新型维生素C衍生物2-O-β- d -葡萄糖吡喃酰基- l-抗坏血酸:资源、生物合成及应用
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.11.002
Mengyue Wang , Haotian Wu , Li Xiang , Ranran Gao , Qinggang Yin , Yang Chu , Lan Wu , Yanyan Su , Gangqiang Dong , Yuhua Shi
As the only naturally occurring stable derivative of L-ascorbic acid (AA; vitamin C), 2-O-β-D-glucopyranosyl-L-ascorbic acid (AA-2βG) is hydrolyzed in vivo to release active AA. AA-2βG exhibits strong antioxidant and antiphotoaging effects comparable to those of AA, and it plays a key role in maintaining organismal health. Owing to its superior stability and bioavailability, AA-2βG is considered as a promising, longer-lasting natural alternative to conventional vitamin C. It was first identified and is particularly abundant in Lycii Fructus (Gouqizi in Chinese) but has been detected in several crop plants. This review offers a comprehensive overview of recent advances in AA-2βG research, covering key aspects including discovery, structure, natural sources, extraction and detection methods, chemical and in vitro enzymatic synthesis, biosynthetic pathways, as well as applications in health care, skin care, and functional foods. Additionally, we highlight strategies for leveraging plant resources and enhancing AA-2βG biosynthesis, which are expected to accelerate future research and support the sustainable development and utilization of AA-2βG and other high-value natural products.
作为l-抗坏血酸(AA;维生素C)唯一天然存在的稳定衍生物,2-O-β- d -葡萄糖吡喃基- l-抗坏血酸(AA-2β g)在体内水解释放出活性AA。AA-2β g具有与AA相当的抗氧化和抗光老化作用,在维持机体健康中起关键作用。由于其优越的稳定性和生物利用度,AA-2βG被认为是一种有前途的、持久的天然维生素c替代品。它最早被发现,在枸杞子中含量特别丰富,但在几种作物植物中也被检测到。本文综述了AA-2βG的发现、结构、天然来源、提取和检测方法、化学和体外酶合成、生物合成途径以及在保健、护肤和功能食品中的应用等方面的研究进展。此外,我们还强调了利用植物资源和促进AA-2βG生物合成的策略,以期加快未来的研究,并支持AA-2βG和其他高价值天然产物的可持续开发和利用。
{"title":"Natural novel vitamin C derivative, 2-O-β-D-glucopyranosyl-L-ascorbic acid: Resources, biosynthesis, and applications","authors":"Mengyue Wang ,&nbsp;Haotian Wu ,&nbsp;Li Xiang ,&nbsp;Ranran Gao ,&nbsp;Qinggang Yin ,&nbsp;Yang Chu ,&nbsp;Lan Wu ,&nbsp;Yanyan Su ,&nbsp;Gangqiang Dong ,&nbsp;Yuhua Shi","doi":"10.1016/j.chmed.2025.11.002","DOIUrl":"10.1016/j.chmed.2025.11.002","url":null,"abstract":"<div><div>As the only naturally occurring stable derivative of <em>L-</em>ascorbic acid (AA; vitamin C), 2-<em>O</em>-<em>β</em>-<em>D</em>-glucopyranosyl-<em>L</em>-ascorbic acid (AA-2<em>β</em>G) is hydrolyzed <em>in vivo</em> to release active AA. AA-2<em>β</em>G exhibits strong antioxidant and antiphotoaging effects comparable to those of AA, and it plays a key role in maintaining organismal health. Owing to its superior stability and bioavailability, AA-2<em>β</em>G is considered as a promising, longer-lasting natural alternative to conventional vitamin C. It was first identified and is particularly abundant in <em>Lycii Fructus</em> (Gouqizi in Chinese) but has been detected in several crop plants. This review offers a comprehensive overview of recent advances in AA-2<em>β</em>G research, covering key aspects including discovery, structure, natural sources, extraction and detection methods, chemical and <em>in vitro</em> enzymatic synthesis, biosynthetic pathways, as well as applications in health care, skin care, and functional foods. Additionally, we highlight strategies for leveraging plant resources and enhancing AA-2<em>β</em>G biosynthesis, which are expected to accelerate future research and support the sustainable development and utilization of AA-2<em>β</em>G and other high-value natural products.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 77-88"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in microbial biosynthesis of indirubin 微生物合成靛玉红的研究进展
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.11.004
Keqian Li , Fangyu Xiang , Xin Yang , Mengqi Liu , Rui Long , Li Han , Ming Yang , Dingkun Zhang , Yanan He
Indirubin (IND), a bisindole alkaloid with remarkable pharmacological activities, has attracted significant attention in the pharmaceutical field due to its antileukemic, anti-inflammatory, and immunomodulatory properties. Currently, indirubin primarily relies on plant extraction and chemical synthesis, which are hindered by complex processes, low yields, and poor environmental compatibility. These challenges pose serious obstacles to clinical supply and sustainable industrial development. In recent years, microbial synthesis technology, which is based on synthetic biology and metabolic engineering, has provided a novel approach for the efficient production of indirubin. This method offers several advantages, including high efficiency, environmental sustainability, and eco-friendliness. Hence, this manuscript systematically summarizes the biosynthesis mechanisms of indirubin, the catalytic characteristics of key enzymes, the construction strategies of engineered bacteria, and the progress in fermentation condition. To address challenges such as the difficult separation of indirubin isomers, by-product inhibition, and industrialization bottlenecks, potential solutions are proposed, aiming to promote the green biomanufacturing of indirubin.
Indirubin (IND)是一种具有显著药理活性的双吲哚类生物碱,因其抗白血病、抗炎和免疫调节等特性而引起了医药领域的广泛关注。目前,靛玉红主要依靠植物提取和化学合成,工艺复杂、产率低、环境相容性差。这些挑战对临床供应和可持续工业发展构成严重障碍。近年来,以合成生物学和代谢工程为基础的微生物合成技术为靛玉红的高效生产提供了一条新的途径。这种方法具有效率高、环境可持续性和生态友好性等优点。为此,本文系统综述了靛玉红的生物合成机理、关键酶的催化特性、工程菌的构建策略以及发酵条件的研究进展。针对靛玉红异构体分离困难、副产物抑制和产业化瓶颈等问题,提出了潜在的解决方案,旨在促进靛玉红的绿色生物制造。
{"title":"Advances in microbial biosynthesis of indirubin","authors":"Keqian Li ,&nbsp;Fangyu Xiang ,&nbsp;Xin Yang ,&nbsp;Mengqi Liu ,&nbsp;Rui Long ,&nbsp;Li Han ,&nbsp;Ming Yang ,&nbsp;Dingkun Zhang ,&nbsp;Yanan He","doi":"10.1016/j.chmed.2025.11.004","DOIUrl":"10.1016/j.chmed.2025.11.004","url":null,"abstract":"<div><div>Indirubin (IND), a bisindole alkaloid with remarkable pharmacological activities, has attracted significant attention in the pharmaceutical field due to its antileukemic, anti-inflammatory, and immunomodulatory properties. Currently, indirubin primarily relies on plant extraction and chemical synthesis, which are hindered by complex processes, low yields, and poor environmental compatibility. These challenges pose serious obstacles to clinical supply and sustainable industrial development. In recent years, microbial synthesis technology, which is based on synthetic biology and metabolic engineering, has provided a novel approach for the efficient production of indirubin. This method offers several advantages, including high efficiency, environmental sustainability, and eco-friendliness. Hence, this manuscript systematically summarizes the biosynthesis mechanisms of indirubin, the catalytic characteristics of key enzymes, the construction strategies of engineered bacteria, and the progress in fermentation condition. To address challenges such as the difficult separation of indirubin isomers, by-product inhibition, and industrialization bottlenecks, potential solutions are proposed, aiming to promote the green biomanufacturing of indirubin.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 45-58"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Astragalus polysaccharides inhibit arsenic trioxide-induced BMSCs damage through inhibition of Jnk and p38 signaling pathways 黄芪多糖通过抑制Jnk和p38信号通路抑制三氧化二砷诱导的骨髓间质干细胞损伤
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.03.007
Wei Wu , Djibril Bamba , Zheng Zhang , Feng Wu , Yuan Li , Wenyi Qi , Yingzhe Liu , Tingting Zhang , Ying Su , Xinyue Wang , Hongbo Wang , Shuqin Duan , Jingwen Ne , Wenbo Wang , Jingwei Liu , Jianyong Tang , Fengda Li , Qingchao Wu , Yang Li , Fan Yang , Lei Yang

Objective

Arsenic trioxide (ATO) is a clinically effective anticancer agent used in the treatment of leukemia. However, it exerts adverse effects on non-tumor cells, including bone marrow mesenchymal stem cells (BMSCs). This study aims to investigate the protective role and molecular mechanism of traditional Chinese medicine Astragalus polysaccharides (APS) in mitigating ATO-induced apoptosis in BMSCs.

Methods

BMSCs exposed to ATO (0.5 μmol/L) were treated with APS (20, 40, 100, and 200 μg/mL). Cell viability, proliferation, and migration were assessed by using MTT, EdU staining, Transwell, and scratch wound healing assays. Apoptosis was evaluated via TUNEL assay, Hoechst 33258 staining, and flow cytometry. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential were measured by using DCFH-DA and JC-1 staining. Apoptotic protein expression was analyzed by Western blotting.

Results

ATO exposure significantly inhibited the proliferation and migration of BMSCs and induced apoptosis, while APS markedly attenuated the apoptosis of BMSCs induced by ATO, and significantly improved cell proliferation and migration (P < 0.01). Mechanistically, APS effectively reduced ATO-induced ROS (P < 0.01), while the protein expression of Bcl-2-associated X protein (Bax) and cleaved Caspase-3 was significantly decreased (P < 0.05), and the protein expression of Bcl-2 was significantly increased (P < 0.01). In addition, APS markedly decreased the protein expression of c-Jun N-terminal kinase (Jnk) and p38 in ATO-activated BMSCs (P < 0.05), and significantly decreased the protein expression of p16 and p53 (P < 0.01), and increased the protein expression of phosphorylated protein kinase B (p-Akt) and phosphorylated extracellular signal-regulated kinase (p-Erk) (P < 0.01, 0.05).

Conclusion

Our study reveals that APS exert significant protective effects against ATO-induced apoptosis in BMSCs. The mechanisms involve suppressing ROS generation, maintaining mitochondrial membrane stability, enhancing cell viability, migration, and proliferation, as well as inhibiting Jnk and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways. The findings highlight potential molecular targets and novel strategies for the clinical prevention and treatment of ATO-related toxicity.
目的三氧化二砷(ATO)是临床上治疗白血病的有效抗癌药物。然而,它对非肿瘤细胞,包括骨髓间充质干细胞(BMSCs)有不利影响。本研究旨在探讨中药黄芪多糖(Astragalus polysaccharides, APS)对ato诱导的骨髓间充质干细胞凋亡的保护作用及其分子机制。方法分别用APS(20、40、100、200 μmol/ mL)处理ATO (0.5 μmol/L)暴露的骨髓间充质干细胞。通过MTT、EdU染色、Transwell和抓伤愈合试验评估细胞活力、增殖和迁移。TUNEL法、Hoechst 33258染色、流式细胞术检测细胞凋亡。DCFH-DA和JC-1染色检测细胞内活性氧(ROS)和线粒体膜电位。Western blotting分析凋亡蛋白的表达。结果佐藤暴露可显著抑制骨髓间充质干细胞的增殖和迁移,诱导细胞凋亡,而黄芪多糖可显著减弱ATO诱导的骨髓间充质干细胞的凋亡,显著促进细胞增殖和迁移(P < 0.01)。机制上,APS有效降低了ato诱导的ROS (P < 0.01), Bcl-2相关X蛋白(Bax)和cleaved Caspase-3蛋白表达量显著降低(P < 0.05), Bcl-2蛋白表达量显著升高(P < 0.01)。此外,APS显著降低了ato激活的骨髓间充质干细胞中c-Jun n -末端激酶(Jnk)和p38的蛋白表达(P < 0.05),显著降低了p16和p53的蛋白表达(P < 0.01),提高了磷酸化蛋白激酶B (P < akt)和磷酸化细胞外信号调节激酶(P < 0.01, 0.05)的蛋白表达。结论黄芪多糖对ato诱导的骨髓间充质干细胞凋亡具有明显的保护作用。其机制包括抑制ROS的产生,维持线粒体膜的稳定性,增强细胞活力、迁移和增殖,以及抑制Jnk和p38丝裂原活化蛋白激酶(p38 MAPK)信号通路。这些发现强调了ato相关毒性的临床预防和治疗的潜在分子靶点和新策略。
{"title":"Astragalus polysaccharides inhibit arsenic trioxide-induced BMSCs damage through inhibition of Jnk and p38 signaling pathways","authors":"Wei Wu ,&nbsp;Djibril Bamba ,&nbsp;Zheng Zhang ,&nbsp;Feng Wu ,&nbsp;Yuan Li ,&nbsp;Wenyi Qi ,&nbsp;Yingzhe Liu ,&nbsp;Tingting Zhang ,&nbsp;Ying Su ,&nbsp;Xinyue Wang ,&nbsp;Hongbo Wang ,&nbsp;Shuqin Duan ,&nbsp;Jingwen Ne ,&nbsp;Wenbo Wang ,&nbsp;Jingwei Liu ,&nbsp;Jianyong Tang ,&nbsp;Fengda Li ,&nbsp;Qingchao Wu ,&nbsp;Yang Li ,&nbsp;Fan Yang ,&nbsp;Lei Yang","doi":"10.1016/j.chmed.2025.03.007","DOIUrl":"10.1016/j.chmed.2025.03.007","url":null,"abstract":"<div><h3>Objective</h3><div>Arsenic trioxide (ATO) is a clinically effective anticancer agent used in the treatment of leukemia. However, it exerts adverse effects on non-tumor cells, including bone marrow mesenchymal stem cells (BMSCs). This study aims to investigate the protective role and molecular mechanism of traditional Chinese medicine Astragalus polysaccharides (APS) in mitigating ATO-induced apoptosis in BMSCs.</div></div><div><h3>Methods</h3><div>BMSCs exposed to ATO (0.5 μmol/L) were treated with APS (20, 40, 100, and 200 μg/mL). Cell viability, proliferation, and migration were assessed by using MTT, EdU staining, Transwell, and scratch wound healing assays. Apoptosis was evaluated via TUNEL assay, Hoechst 33258 staining, and flow cytometry. Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential were measured by using DCFH-DA and JC-1 staining. Apoptotic protein expression was analyzed by Western blotting.</div></div><div><h3>Results</h3><div>ATO exposure significantly inhibited the proliferation and migration of BMSCs and induced apoptosis, while APS markedly attenuated the apoptosis of BMSCs induced by ATO, and significantly improved cell proliferation and migration (<em>P</em> &lt; 0.01). Mechanistically, APS effectively reduced ATO-induced ROS (<em>P</em> &lt; 0.01), while the protein expression of Bcl-2-associated X protein (Bax) and cleaved Caspase-3 was significantly decreased (<em>P</em> &lt; 0.05), and the protein expression of Bcl-2 was significantly increased (<em>P</em> &lt; 0.01). In addition, APS markedly decreased the protein expression of c-Jun <em>N</em>-terminal kinase (Jnk) and p38 in ATO-activated BMSCs (<em>P</em> &lt; 0.05), and significantly decreased the protein expression of p16 and p53 (<em>P</em> &lt; 0.01), and increased the protein expression of phosphorylated protein kinase B (p-Akt) and phosphorylated extracellular signal-regulated kinase (p-Erk) (<em>P</em> &lt; 0.01, 0.05).</div></div><div><h3>Conclusion</h3><div>Our study reveals that APS exert significant protective effects against ATO-induced apoptosis in BMSCs. The mechanisms involve suppressing ROS generation, maintaining mitochondrial membrane stability, enhancing cell viability, migration, and proliferation, as well as inhibiting Jnk and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways. The findings highlight potential molecular targets and novel strategies for the clinical prevention and treatment of ATO-related toxicity<strong><em>.</em></strong></div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 178-187"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancement of levopimaradiene production in Escherichia coli via engineering isopentenol utilization pathway 利用异戊烯醇工程途径提高大肠杆菌左旋旋己二烯产量
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.11.003
Chenhao Jia , Junying Ma , Lingli Fang , Huanzi Guo , Meiling Ding , Yishuang Wang , Renxiang Tan

Objective

Plant-derived terpenoid ginkgolides exhibit significant pharmacological efficacy, however, their extraction remains costly. Given that levopimaradiene is a key biosynthetic precursor to ginkgolides, its high-yield production via heterologous gene expression therefore establishes a critical foundation for scaling up their manufacture. This study primarily aims to enhance the yield of levopimaradiene in Escherichia coli (LB medium) by remodeling the unnatural isopentenol utilization pathway (IUP).

Methods

Plasmid construction was driven by the mechanism of homologous recombination, which utilizes recombinase to facilitate the ligation process. The expression of kinase was carried out using type 7 (T7) promoter and isopropyl β-D-1-thiogalactopyranoside (IPTG) as the inducer. The quantification of levopimaradiene produced by E. coli was determined by comparison with a standard curve that we constructed.

Results

Combining the selection of kinases, ribosome-binding site (RBS) screening, protein directed evolution and optimization of fermentation parameters, the production of levopimaradiene in E. coli was ultimately enhanced to 2691.3 mg/L, surpassing the highest reported titers of levopimaradiene with 6-fold in E. coli to date. Additionally, the engineered E. coli was designed to collaborate with farnesyl pyrophosphate (FPP) synthase and geranylfarnesyl pyrophosphate (GFPP) synthase to efficiently produce FPP and GFPP for sesquiterpene and sesterterpene synthesis.

Conclusion

Our work showcases a combinatorial engineering strategy that employs an IUP-enhanced E. coli chassis for the microbial production of levopimaradiene, as well as other natural terpenoids.
目的植物源性萜类银杏内酯具有显著的药理作用,但其提取成本较高。鉴于左旋马二烯是银杏内酯的关键生物合成前体,因此通过异源基因表达的高产量生产为扩大银杏内酯的生产规模奠定了重要基础。本研究主要目的是通过重塑非自然异戊烯醇利用途径(IUP),提高大肠杆菌(LB培养基)中左旋马二烯的产率。方法利用同源重组机制,利用重组酶促进连接过程,构建asmid。以7型启动子(T7)和异丙基β- d -1-硫代半乳糖苷(IPTG)为诱导剂进行激酶的表达。通过与我们构建的标准曲线比较,确定了大肠杆菌产生的左旋马二烯的定量。结果结合激酶选择、核糖体结合位点筛选、蛋白定向进化和发酵参数优化,最终使大肠杆菌的左旋马二烯产量提高到2691.3 mg/L,是迄今为止报道的大肠杆菌左旋马二烯滴度的6倍。此外,设计的工程大肠杆菌与法尼基焦磷酸(FPP)合成酶和香叶基法尼基焦磷酸(GFPP)合成酶协同高效生产FPP和GFPP,用于倍半萜和二萜的合成。我们的工作展示了一种组合工程策略,该策略采用iop增强的大肠杆菌底盘,用于微生物生产左旋马二烯和其他天然萜类。
{"title":"Enhancement of levopimaradiene production in Escherichia coli via engineering isopentenol utilization pathway","authors":"Chenhao Jia ,&nbsp;Junying Ma ,&nbsp;Lingli Fang ,&nbsp;Huanzi Guo ,&nbsp;Meiling Ding ,&nbsp;Yishuang Wang ,&nbsp;Renxiang Tan","doi":"10.1016/j.chmed.2025.11.003","DOIUrl":"10.1016/j.chmed.2025.11.003","url":null,"abstract":"<div><h3>Objective</h3><div>Plant-derived terpenoid ginkgolides exhibit significant pharmacological efficacy, however, their extraction remains costly. Given that levopimaradiene is a key biosynthetic precursor to ginkgolides, its high-yield production via heterologous gene expression therefore establishes a critical foundation for scaling up their manufacture. This study primarily aims to enhance the yield of levopimaradiene in <em>Escherichia coli</em> (LB medium) by remodeling the unnatural isopentenol utilization pathway (IUP).</div></div><div><h3>Methods</h3><div>Plasmid construction was driven by the mechanism of homologous recombination, which utilizes recombinase to facilitate the ligation process. The expression of kinase was carried out using type 7 (T7) promoter and isopropyl <em>β</em>-<em>D</em>-1-thiogalactopyranoside (IPTG) as the inducer. The quantification of levopimaradiene produced by E. coli was determined by comparison with a standard curve that we constructed.</div></div><div><h3>Results</h3><div>Combining the selection of kinases, ribosome-binding site (RBS) screening, protein directed evolution and optimization of fermentation parameters, the production of levopimaradiene in <em>E. coli</em> was ultimately enhanced to 2691.3 mg/L, surpassing the highest reported titers of levopimaradiene with 6-fold in <em>E. coli</em> to date. Additionally, the engineered <em>E. coli</em> was designed to collaborate with farnesyl pyrophosphate (FPP) synthase and geranylfarnesyl pyrophosphate (GFPP) synthase to efficiently produce FPP and GFPP for sesquiterpene and sesterterpene synthesis.</div></div><div><h3>Conclusion</h3><div>Our work showcases a combinatorial engineering strategy that employs an IUP-enhanced <em>E. coli</em> chassis for the microbial production of levopimaradiene, as well as other natural terpenoids.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 89-96"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safflower yellow in Carthami Flos is responsible for Xuebijing Injection-induced immediate hypersensitivity reaction through activating complement C3 红花中的红花黄通过激活补体C3导致血必净注射液诱导的即刻超敏反应
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2024.06.003
Wenjing Li , Yuan Gao , Jingjing Yan, Min Cai, Chenchen Zang, Zhuangzhuang Liu, Ximeng Li, Runlan Cai, Yun Qi

Objective

Xuebijing Injection (XBJI) is mainly used for treating sepsis in China, and even COVID-19 recently. This study aimed to clarify the molecular mechanism(s) and identify the potential “common culprit(s)” for XBJI-caused immediate hypersensitivity reaction (IHR) which is the main type of its adverse reactions.

Methods

Antiserum against XBJI was prepared by intraperitoneal immunization in combination with aluminum adjuvant for five weeks. Antagonistic experiments were performed by using several antagonists against different mediators in Evans Blue leakage model. Propranolol-pretreated mice were used to determine the capacity of XBJI to trigger systemic IHR. Serum total IgE (tIgE) and mouse mast cell protease 1 (MCPT-1) levels, complement activation, and the levels of supernatant inflammatory mediators were determined by ELISAs. Lipopolysaccharide (LPS)-activated RAW264.7 macrophages were used for evaluating the anti-inflammatory activity of XBJI, while human mast cells (LAD2) were used for assessing the effect of XBJI on mast cell degranulation.

Results

Continuous treatment (i.p.) with XBJI along with aluminum adjuvant did not elevate the levels of serum tIgE and MCPT-1. In vitro, XBJI could not directly cause the degranulation of LAD2 cells. It induced a robust Evans Blue leakage after the first injection in mouse paw. Mechanism study demonstrated that antagonists for histamine H1/H2 receptors and complement C3a receptor counteracted XBJI-induced IHR. XBJI also directly activated complement C3 in human serum. Through screening five herbs of XBJI and the constituents, only safflower yellow (SY) in Carthami Flos was able to induce IHR. The discolored-XBJI not only did not induce IHR locally and systemically, but also could suppressing the production of proinflammatory mediators in LPS-activated RAW264.7 macrophages.

Conclusion

XBJI failed to induce immune IHR, but potently triggered non-immune IHR through direct activating complement C3 to provoke histamine release. SY in Carthami Flos was the underlying “common culprit” responsible for XBJI-caused IHR. The anti-inflammatory action of XBJI can be retained after decolorization. Our study provides a scientific basis for not only preventing and treating XBJI-caused IHR clinically, but also improving its production process.
目的微血净注射液(XBJI)目前在中国主要用于治疗脓毒症,甚至是COVID-19。本研究旨在阐明xbji致立即超敏反应(IHR)的分子机制,并确定其潜在的“共同罪魁祸首”,IHR是xbji的主要不良反应类型。方法采用铝佐剂联合腹腔免疫5周制备抗XBJI血清。在Evans Blue渗漏模型中,采用几种拮抗剂对不同介质进行拮抗实验。用经心得安预处理的小鼠测定XBJI触发全身IHR的能力。采用elisa法检测血清总IgE (tIgE)、小鼠肥大细胞蛋白酶1 (MCPT-1)水平、补体活化及炎症介质上清水平。采用脂多糖(LPS)活化RAW264.7巨噬细胞评价XBJI的抗炎活性,采用人肥大细胞(LAD2)评价XBJI对肥大细胞脱颗粒的影响。结果连续使用XBJI联合铝佐剂治疗后,血清tIgE和MCPT-1水平均未升高。在体外,XBJI不能直接引起LAD2细胞的脱粒。首次注射后,小鼠爪内出现明显的埃文斯蓝渗漏。机制研究表明,组胺H1/H2受体和补体C3a受体拮抗剂可抵消xbji诱导的IHR。XBJI还能直接激活人血清中的补体C3。通过筛选XBJI的5种药材及其成分,红花中只有红花黄(SY)能诱导IHR。脱色后的xbji不仅不会引起局部和全身的IHR,而且可以抑制lps激活的RAW264.7巨噬细胞中促炎介质的产生。结论xbji不能诱导免疫性IHR,但可通过直接激活补体C3刺激组胺释放而有效触发非免疫性IHR。Carthami Flos的SY是xbji引起的国际卫生条例的潜在“共同罪魁祸首”。XBJI的抗炎作用在脱色后仍能保留。本研究不仅为临床预防和治疗xbji引起的IHR提供了科学依据,也为改进其生产工艺提供了科学依据。
{"title":"Safflower yellow in Carthami Flos is responsible for Xuebijing Injection-induced immediate hypersensitivity reaction through activating complement C3","authors":"Wenjing Li ,&nbsp;Yuan Gao ,&nbsp;Jingjing Yan,&nbsp;Min Cai,&nbsp;Chenchen Zang,&nbsp;Zhuangzhuang Liu,&nbsp;Ximeng Li,&nbsp;Runlan Cai,&nbsp;Yun Qi","doi":"10.1016/j.chmed.2024.06.003","DOIUrl":"10.1016/j.chmed.2024.06.003","url":null,"abstract":"<div><h3>Objective</h3><div>Xuebijing Injection (XBJI) is mainly used for treating sepsis in China, and even COVID-19 recently. This study aimed to clarify the molecular mechanism(s) and identify the potential “common culprit(s)” for XBJI-caused immediate hypersensitivity reaction (IHR) which is the main type of its adverse reactions.</div></div><div><h3>Methods</h3><div>Antiserum against XBJI was prepared by intraperitoneal immunization in combination with aluminum adjuvant for five weeks. Antagonistic experiments were performed by using several antagonists against different mediators in Evans Blue leakage model. Propranolol-pretreated mice were used to determine the capacity of XBJI to trigger systemic IHR. Serum total IgE (tIgE) and mouse mast cell protease 1 (MCPT-1) levels, complement activation, and the levels of supernatant inflammatory mediators were determined by ELISAs. Lipopolysaccharide (LPS)-activated RAW264.7 macrophages were used for evaluating the anti-inflammatory activity of XBJI, while human mast cells (LAD2) were used for assessing the effect of XBJI on mast cell degranulation.</div></div><div><h3>Results</h3><div>Continuous treatment (<em>i.p.</em>) with XBJI along with aluminum adjuvant did not elevate the levels of serum tIgE and MCPT-1. <em>In vitro</em>, XBJI could not directly cause the degranulation of LAD2 cells. It induced a robust Evans Blue leakage after the first injection in mouse paw. Mechanism study demonstrated that antagonists for histamine H1/H2 receptors and complement C3a receptor counteracted XBJI-induced IHR. XBJI also directly activated complement C3 in human serum. Through screening five herbs of XBJI and the constituents, only safflower yellow (SY) in <em>Carthami Flos</em> was able to induce IHR. The discolored-XBJI not only did not induce IHR locally and systemically, but also could suppressing the production of proinflammatory mediators in LPS-activated RAW264.7 macrophages.</div></div><div><h3>Conclusion</h3><div>XBJI failed to induce immune IHR, but potently triggered non-immune IHR through direct activating complement C3 to provoke histamine release. SY in <em>Carthami Flos</em> was the underlying “common culprit” responsible for XBJI-caused IHR. The anti-inflammatory action of XBJI can be retained after decolorization. Our study provides a scientific basis for not only preventing and treating XBJI-caused IHR clinically, but also improving its production process.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 188-199"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein S-acylation: Pathological mechanisms and novel therapeutic targets for diabetic complications 蛋白s -酰化:糖尿病并发症的病理机制和新的治疗靶点
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.02.009
Ruiting Liu , Nuo Xu , Xuejiao Song , Yanying Li , Jie Bu , Runtao Su , Hong Guo , Chen Jiang , Pengwei Zhuang , Yanjun Zhang , Qingsheng Yin
Diabetes involves multi-organ complications that seriously threaten human life and health, and has become a major public health problem of global concern. Unfortunately, clinical management strategies for diabetic complications are still in their “infancy”, restricted by a limited understanding of their complex pathological mechanism. As is well established, lipid metabolism disorder is the characteristic pathological factors of diabetes, but the detailed molecular mechanisms driving the progression of multi-organ complications remain obscure. Protein S-acylation (often referred to as S-palmitoylation) is a reversible lipid modification that reversibly binds fatty acids to protein-specific cysteine (Cys) residues through palmitoyl acyl transferases (PATs, also known as DHHCs) and deacylation enzymes, which is involved in the pathological progression of a variety of complex diseases such as cancer, neurological disorders and metabolic syndrome. Notably, recent studies have shown that protein S-acylation drives the progression of diabetes and its multiple complications, and targeted intervention in the protein S-acylation process significantly alleviates the progression of diabetes and its complications, suggesting that protein S-acylation may be a common pathological link and intervention target of diabetes complications. Therefore, this review systematically comprehends the contribution of protein S-acylation to the progression of diabetes and its complications, summarizes the influence of the diabetic environment on S-acylation related enzymes, as well as providing an in-depth analysis of current drugs, measures, and challenges in targeting S-acylation. Finally, the accessibility of targeting protein S-acylation to prevent diabetes and its complications and the focus of future in-depth studies are envisioned, with a view to providing comprehensive and in-depth references and rationale for future novel strategies targeting protein S-acylation to prevent and treat diabetes and its multi-organ complications.
糖尿病涉及多器官并发症,严重威胁人类生命和健康,已成为全球关注的重大公共卫生问题。不幸的是,糖尿病并发症的临床管理策略仍处于“婴儿期”,对其复杂的病理机制了解有限。脂质代谢紊乱是糖尿病的特征性病理因素,但驱动多器官并发症进展的详细分子机制尚不清楚。蛋白质s -酰化(通常称为s -棕榈酰化)是一种可逆的脂质修饰,通过棕榈酰酰基转移酶(PATs,也称为dhhc)和去酰化酶将脂肪酸与蛋白质特异性半胱氨酸(Cys)残基可逆结合,参与多种复杂疾病如癌症、神经系统疾病和代谢综合征的病理进展。值得注意的是,最近的研究表明,蛋白质s -酰化驱动糖尿病及其多种并发症的进展,有针对性地干预蛋白质s -酰化过程可显著缓解糖尿病及其并发症的进展,提示蛋白质s -酰化可能是糖尿病并发症的共同病理环节和干预靶点。因此,本文将系统地了解蛋白质s -酰化对糖尿病及其并发症进展的贡献,总结糖尿病环境对s -酰化相关酶的影响,并对目前针对s -酰化的药物、措施和挑战进行深入分析。最后,展望了靶向s -酰化蛋白预防糖尿病及其并发症的可及性和未来深入研究的重点,以期为未来靶向s -酰化蛋白预防和治疗糖尿病及其多器官并发症的新策略提供全面深入的参考和理论依据。
{"title":"Protein S-acylation: Pathological mechanisms and novel therapeutic targets for diabetic complications","authors":"Ruiting Liu ,&nbsp;Nuo Xu ,&nbsp;Xuejiao Song ,&nbsp;Yanying Li ,&nbsp;Jie Bu ,&nbsp;Runtao Su ,&nbsp;Hong Guo ,&nbsp;Chen Jiang ,&nbsp;Pengwei Zhuang ,&nbsp;Yanjun Zhang ,&nbsp;Qingsheng Yin","doi":"10.1016/j.chmed.2025.02.009","DOIUrl":"10.1016/j.chmed.2025.02.009","url":null,"abstract":"<div><div>Diabetes involves multi-organ complications that seriously threaten human life and health, and has become a major public health problem of global concern. Unfortunately, clinical management strategies for diabetic complications are still in their “infancy”, restricted by a limited understanding of their complex pathological mechanism. As is well established, lipid metabolism disorder is the characteristic pathological factors of diabetes, but the detailed molecular mechanisms driving the progression of multi-organ complications remain obscure. Protein S-acylation (often referred to as S-palmitoylation) is a reversible lipid modification that reversibly binds fatty acids to protein-specific cysteine (Cys) residues through palmitoyl acyl transferases (PATs, also known as DHHCs) and deacylation enzymes, which is involved in the pathological progression of a variety of complex diseases such as cancer, neurological disorders and metabolic syndrome. Notably, recent studies have shown that protein S-acylation drives the progression of diabetes and its multiple complications, and targeted intervention in the protein S-acylation process significantly alleviates the progression of diabetes and its complications, suggesting that protein S-acylation may be a common pathological link and intervention target of diabetes complications. Therefore, this review systematically comprehends the contribution of protein S-acylation to the progression of diabetes and its complications, summarizes the influence of the diabetic environment on S-acylation related enzymes, as well as providing an in-depth analysis of current drugs, measures, and challenges in targeting S-acylation. Finally, the accessibility of targeting protein S-acylation to prevent diabetes and its complications and the focus of future in-depth studies are envisioned, with a view to providing comprehensive and in-depth references and rationale for future novel strategies targeting protein S-acylation to prevent and treat diabetes and its multi-organ complications.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 110-123"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herbgenomics: Unraveling natural product biosynthesis in traditional Chinese medicine 草药基因组学:揭示中药天然产物的生物合成
IF 8.9 4区 医学 Q1 CHEMISTRY, MEDICINAL Pub Date : 2026-01-01 DOI: 10.1016/j.chmed.2025.11.008
Jing Wang , Jingyuan Song , Shilin Chen , Zhichao Xu
Medicinal plants synthesize structurally diverse pharmacologically active natural products through conserved precursor pathways, which are further diversified by lineage-specific tailoring enzymes. Although the biosynthetic pathways of well-studied compounds (e.g., berberine, paclitaxel, and ginsenosides) have been extensively characterized, most bioactive components in Traditional Chinese Medicine (TCM) remain poorly understood. The emerging discipline of Herbgenomics has significantly advanced biosynthetic gene discovery and pathway elucidation. By employing genomics-driven strategies such as biosynthetic gene cluster mining, co-expression analysis, and integrated transcriptome-metabolome profiling, Herbgenomics enables systematic identification of key biosynthetic enzymes and uncovers evolutionary mechanisms (e.g., whole-genome and tandem gene duplications) driving metabolic innovation. Furthermore, it provides a foundation for drug development by leveraging gene-encoded natural diverse components and genome-wide pan-receptor platforms (e.g., pan-GPCR). Through the integration of pathway analysis, regulatory mechanisms, molecular breeding, and synthetic biology, Herbgenomics establishes a comprehensive framework for exploring and engineering TCM natural product biosynthesis, offering a sustainable pathway to the discovery and production of bioactive compounds.
药用植物通过保守的前体途径合成结构多样的具有药理活性的天然产物,这些前体途径通过谱系特异性剪裁酶进一步多样化。尽管已被充分研究的化合物(如小檗碱、紫杉醇和人参皂苷)的生物合成途径已被广泛表征,但大多数中药(TCM)中的生物活性成分仍然知之甚少。新兴的草药基因组学学科显著地促进了生物合成基因的发现和途径的阐明。通过采用基因组学驱动的策略,如生物合成基因簇挖掘、共表达分析和整合转录组-代谢组分析,Herbgenomics能够系统地识别关键的生物合成酶,并揭示驱动代谢创新的进化机制(例如,全基因组和串联基因复制)。此外,它通过利用基因编码的天然多样化成分和全基因组泛受体平台(例如,泛gpcr)为药物开发提供了基础。通过途径分析、调控机制、分子育种和合成生物学的整合,Herbgenomics建立了探索和工程中药天然产物生物合成的综合框架,为生物活性化合物的发现和生产提供了可持续的途径。
{"title":"Herbgenomics: Unraveling natural product biosynthesis in traditional Chinese medicine","authors":"Jing Wang ,&nbsp;Jingyuan Song ,&nbsp;Shilin Chen ,&nbsp;Zhichao Xu","doi":"10.1016/j.chmed.2025.11.008","DOIUrl":"10.1016/j.chmed.2025.11.008","url":null,"abstract":"<div><div>Medicinal plants synthesize structurally diverse pharmacologically active natural products through conserved precursor pathways, which are further diversified by lineage-specific tailoring enzymes. Although the biosynthetic pathways of well-studied compounds (e.g., berberine, paclitaxel, and ginsenosides) have been extensively characterized, most bioactive components in Traditional Chinese Medicine (TCM) remain poorly understood. The emerging discipline of Herbgenomics has significantly advanced biosynthetic gene discovery and pathway elucidation. By employing genomics-driven strategies such as biosynthetic gene cluster mining, co-expression analysis, and integrated transcriptome-metabolome profiling, Herbgenomics enables systematic identification of key biosynthetic enzymes and uncovers evolutionary mechanisms (e.g., whole-genome and tandem gene duplications) driving metabolic innovation. Furthermore, it provides a foundation for drug development by leveraging gene-encoded natural diverse components and genome-wide pan-receptor platforms (e.g., pan-GPCR). Through the integration of pathway analysis, regulatory mechanisms, molecular breeding, and synthetic biology, Herbgenomics establishes a comprehensive framework for exploring and engineering TCM natural product biosynthesis, offering a sustainable pathway to the discovery and production of bioactive compounds.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"18 1","pages":"Pages 3-10"},"PeriodicalIF":8.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145941437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Herbal Medicines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1